Direct-to the-Public Advertisement of Prescription Drugs

Publisher Website
Google Scholar
Abstract
In 1983, Dr. Arthur Hull Hayes, then commissioner of the Food and Drug Administration, discussed direct-to the-public advertisement of prescription medication in a speech to the Pharmaceutical Advertising Council.1 He noted that such direct promotion had first been discussed in 1981, that discussion had been initiated by the drug industry, and that the FDA had been involved early on in talks with pharmaceutical manufacturers, advertisers, consumer groups, and Congress. He added that "the FDA has serious reservations about pharmaceutical companies and advertisers moving into this uncharted area. . . ."After Dr. Hayes' speech, the FDA asked for and obtained . . .

This publication has 12 references indexed in Scilit: